Delivery Order W81K0213DM001-0001

<p>The Defense Health Agency issued a BPA call to Diasorin Inc. valued at $29,430.10 on September 23, 2025. The call, numbered 0013, was issued under a single-award BPA with the Air Force Materiel Command at Wright-Patterson Air Force Base for diagnostic test kits and reagents, active since March 2021. Work is performed in Stillwater, Minnesota. The call is priced on a firm fixed price basis with no set-aside designation. The ultimate completion date is September 23, 2025.</p>

The Defense Health Agency awarded a purchase order to Roche Diagnostics Corporation on October 1, 2024, for reagents, consumables, and controls for the Cobas 5800 testing system, with a ceiling value of $743,693.30. Performance occurs at Castleton, Indiana. The order is firm fixed price with an ultimate completion date of September 30, 2029. The procurement originated from a Madigan Army Medical Center sources sought notice posted March 18, 2024, seeking a molecular diagnostics analyzer and...

<p>The Defense Health Agency issued a BPA call to Diasorin Inc. on January 9, 2025, for test kits and reagents under the Diasorin BPA with a ceiling value of $22,864.70. Work is performed at Wright-Patterson Air Force Base, Ohio, with an ultimate completion date of January 10, 2025. The call carries firm fixed price pricing and was issued without set-aside.</p>

<p>The Defense Health Agency issued a BPA call to Sebia, Inc. for CDT testing kits valued at $38,025.06, awarded August 1, 2025. Work is performed in Norcross, Georgia, with an ultimate completion date of August 1, 2025. The call is issued under firm fixed-price terms with no set-aside. The scope covers clinical laboratory testing kits for Wright Patterson Air Force Base Medical Center's diagnostic testing requirements.</p>

The Defense Health Agency issued a BPA call to Roche Diagnostics Corporation on March 5, 2026, with a ceiling value of $14,493.42 for mission essential items for laboratory duties (Vitamin D G3). Performance occurs in Castleton, Indiana, with an ultimate completion date of September 30, 2026. The call is firm fixed price with no set-aside designation. This call is issued against an existing parent BPA vehicle; the source does not identify the parent BPA's name or contracting office explicitly.

This is a delivery order issued on September 13, 2024 by the Defense Logistics Agency Troop Support Medical (DLA TROSMED) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for the provision of XPCOV2/FLU/RSV-10 diagnostic test kits. The delivery order, which does not have a set-aside designation, has a firm fixed price ceiling of $5,820.80 and a performance period ending on September 27, 2024. Cepheid is the prime contractor and the original equipment manufacturer for this...

<p>The Defense Health Agency issued a delivery order to Werfen USA LLC on October 1, 2022, for SELF CHECK II 3X5 CRDAMC blood bank test kits, with a ceiling value of $102,874.20 and an ultimate completion date of September 30, 2027.</p> <p>The order was issued under the In Vitro Diagnostics, Reagents, Test GSA Schedule (FSS-65-VII). Place of performance is Peachtree Corners, Georgia. Pricing is firm fixed price, and no set-aside was applied.</p>

<p>The Defense Health Agency issued a BPA call to Roche Diagnostics Corporation on March 12, 2026, for reagents needed for testing, with a ceiling value of $14,915.03 and an ultimate completion date of September 30, 2026. Work will be performed at Castleton, Indiana. The call is priced on a firm fixed-price basis and carries no set-aside designation.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to Cepheid on February 20, 2026, with a ceiling value of $10,200 for KIT XPERT XPRESS COV-2 FLU RSV + MOL BIO diagnostic test kits. The order is firm fixed-price with an ultimate completion date of February 27, 2026. Place of performance is Sunnyvale, CA 94089.</p>

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $16,320.00, is for the provision of the &quot;EUA XPERT XPRESS SARS-COV-2/FLU/RSV+&quot; test kit. This test kit is used for the detection of SARS-CoV-2, influenza, and respiratory syncytial virus. The contract has a fixed price with economic price adjustment pricing type and a completion date of...